This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Fluorinov Pharma Inc.
Drug Names(s): FV-162
Description: FV-162 is a a highly potent, orally-delivered small molecule, second generation selective proteasome inhibitor.
Partners: Ontario Institute for Cancer Research
Pink Sheet Chart: Weekly Trademark Review
Additional information available to subscribers only: